Julian brings investment and banking experience as a general partner at LocalGlobe, Latitude Ventures, Solar, and Phoenix Court, following an advisory role at J.P. Morgan.
Eurazeo led the Series C financing, which will accelerate product development and international expansion.
"This new round allows us to bring forward transformational capabilities that our customers are asking for. By combining full-stack engineering with zero customer complexity, we are building advanced agentic systems powered by the industry’s richest set of real-world logistics data. This will help warehouses and supply chains shift from systems of record to true systems of action."
The robotics and data intelligence firm secured the capital from a syndicate led by DTCP to expand its artificial intelligence platform and global footprint.
"We are incredibly excited about the momentum we’ve built over the past 18 months,"
The investment round was led by Octopus Ventures with participation from multiple returning and strategic backers.
"Automata’s robotic capabilities are truly the first of its kind and the company has combined this with deep expertise in automation and a highly effective business model which has created a leading-edge over competitors. Automata Labs accelerates human ingenuity, empowering labs, and scientists, to achieve consistent results faster, on a greater scale, and to ultimately upscale their ambitions. We are delighted to have led this financing round as Automata represented exactly the type of highly innovative company we invest in and support. We are excited for Automata’s next steps, both within the life sciences industry, and beyond."
The Series B round was led by Lakestar with backing from institutional investors and venture funds to support team growth and product expansion.
"accuRx’s product has reinvigorated communication with our patients, enabling a better relationship between GPs and patients, which has ultimately led to better care provision. Our patients now have the confidence that they’re getting speedy and accurate responses from our team, and the use of regular Florey questionnaires to gather more information from our patients has been transformative for clinical record keeping and the care we provide. We’re thrilled that accuRx has received funding which will enable it to expand its primary care product set, some of which we’re trialling at the moment. We’re also excited about accuRx’s progress into secondary care as better interaction between primary and secondary care is a huge step forward for safer and more effective patient care."
General Catalyst led the round, which will finance the company's international growth strategy and technology scaling.
"We’ve been extremely fortunate in 2020 to accelerate our growth, strengthening our expertise in technology-enabled, customer-centric flower gifting. We’re privileged to have played our part in keeping people connected in this difficult period, and I’m proud of our growing team for scaling our operations whilst maintaining the signature thought and care we put into every order. With this new backing from General Catalyst and Index we start 2021 with renewed energy to pursue our vision of becoming the world’s leading and most loved flower company."
Northzone led the £20m Series B round to support international expansion and strengthen UK market share.
"Where people work and how they work is changing by the day, all the more so since Covid-19 struck. Now the way in which people get paid is changing, too, and at scale. Wagestream provides a financial flexibility that is perfectly suited to today’s agile and progressive workforce."